The Food and Drug Administration has approved a generic medicine for a very rare genetic disorder, while stopping short of authorizing it for autism. The decision, announced this week in
Nvidia’s GTC week isn’t for casual spectators, yet it spills into daily life faster than most tech shows. My view is simple: the real story isn’t new chips—it’s who gets
Scientists are sounding the alarm over the use of artificial intelligence to plan laboratory work, warning that poorly supervised systems could steer researchers into danger. In new testing, 19 different
Oil prices ended the week near their highest levels since 2022, even after the Trump administration said it would temporarily allow deliveries and sales of sanctioned seaborne Russian crude. The
This week’s flood of product demos made one thing clear: interactive learning in chatbots is useful, AI “computers” are still unclear, and creative tools quietly got great. My view is
A new industry report warns that many companies remain exposed to disability-access claims tied to their digital products. AudioEye’s 2026 Accessibility Advantage Report finds that a majority of business leaders
Skywatchers are set for a show next month as a lunar eclipse gives the moon a deep red tint, a sight that can be seen with the naked eye. The
Strategy is adding more bitcoin to its balance sheet even as the market slump leaves the company’s treasury value under its total purchase cost. The move signals a firm commitment
Calling for a change in how public safety is managed, campaigner Rosie Richardson argues that the burden of self-protection should not rest on women alone. Her message, delivered this week